Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Sep-24 7:32 PM View:  | Meyer Andrew Hollman Chief Business Officer | Janux Therapeutics, Inc. (JANX) | 27-Sep-24 | Option Exercise | 50,000 | $4.21 | $210,500.00 | 74% 67.59K to 117.59K | |
| 27-Sep-24 7:32 PM View: | Meyer Andrew Hollman Chief Business Officer | Janux Therapeutics, Inc. (JANX) | 27-Sep-24 | Option Sale | 50,000 | $45.96 | $2,297,760.00 | (43%) 117.59K to 67.59K | |
| 27-Sep-24 7:31 PM View: | Diraimondo Thomas Chief Scientific Officer | Janux Therapeutics, Inc. (JANX) | 27-Sep-24 | Private Sale (Planned) | 5,000 | $46.34 | $231,716.00 | (5%) 102.94K to 97.94K | |
| 27-Sep-24 7:30 PM View: | Campbell David Alan President and CEO Director | Janux Therapeutics, Inc. (JANX) | 27-Sep-24 | Private Sale (Planned) | 25,000 | $46.31 | $1,157,640.00 | (8%) 332.05K to 307.05K | |
| 12-Sep-24 8:42 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 12-Sep-24 | Sale | 158,031 | $47.00 | $7,427,460.00 | (2%) 10.13M to 9.97M | |
| 12-Sep-24 8:42 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 12-Sep-24 | Sale | 191,969 | $47.00 | $9,022,540.00 | (2%) 9.97M to 9.78M | |
| 12-Sep-24 8:42 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 10-Sep-24 | Private Sale | 11,319 | $46.13 | $522,145.00 | (< 1%) 10.23M to 10.22M | |
| 12-Sep-24 8:42 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 10-Sep-24 | Sale | 41,696 | $46.66 | $1,945,540.00 | (< 1%) 10.17M to 10.13M | |
| 12-Sep-24 8:42 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 10-Sep-24 | Sale | 13,750 | $46.13 | $634,288.00 | (< 1%) 10.22M to 10.2M | |
| 12-Sep-24 8:42 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 10-Sep-24 | Sale | 34,326 | $46.66 | $1,601,650.00 | (< 1%) 10.2M to 10.17M | |
| 22-Jul-24 8:03 PM View: | Hernday Natasha Director | Janux Therapeutics, Inc. (JANX) | 19-Jul-24 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 22-Jul-24 8:04 PM View: | Dobmeier Eric Director | Janux Therapeutics, Inc. (JANX) | 19-Jul-24 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 28-Jun-24 4:30 PM View: | Kung Winston Director | Janux Therapeutics, Inc. (JANX) | 26-Jun-24 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 28-Jun-24 4:30 PM View: | Capps Vickie L Director | Janux Therapeutics, Inc. (JANX) | 26-Jun-24 | Grant | 2,500 | -- | -- | 4% 65.54K to 68.04K | |
| 28-Jun-24 4:30 PM View: | Lichter Jay Director 10% Owner | Janux Therapeutics, Inc. (JANX) | 26-Jun-24 | Grant | 2,500 | -- | -- | < 1% 7.25M to 7.25M | |
| 28-Jun-24 4:30 PM View: | Barrett Ronald W Director | Janux Therapeutics, Inc. (JANX) | 26-Jun-24 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 28-Jun-24 4:35 PM View: | Ra Capital Management, LLC Director 10% Owner | Janux Therapeutics, Inc. (JANX) | 26-Jun-24 | Grant Duplicate | 2,500 | -- | -- | < 1% 9.17M to 9.17M | |
| 28-Jun-24 4:30 PM View: | McNulty Alana B. Director | Janux Therapeutics, Inc. (JANX) | 26-Jun-24 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 28-Jun-24 4:30 PM View: | Simson Jake Director | Janux Therapeutics, Inc. (JANX) | 26-Jun-24 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 28-Jun-24 4:30 PM View: | Gujrathi Sheila Director | Janux Therapeutics, Inc. (JANX) | 26-Jun-24 | Grant | 2,500 | -- | -- | 2% 108.03K to 110.53K | |
| 05-Jun-24 7:23 PM View: | Reardon Tighe Acting Chief Financial Officer | Janux Therapeutics, Inc. (JANX) | 03-Jun-24 | Private Sale Duplicate | 822,721 | $54.75 | $45,044,000.00 | (17%) 4.97M to 4.15M | |
| 05-Jun-24 7:19 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 03-Jun-24 | Private Sale | 677,279 | $54.75 | $37,081,000.00 | (8%) 8.74M to 8.07M | |
| 05-Jun-24 7:25 PM View: | Lichter Jay Director 10% Owner | Janux Therapeutics, Inc. (JANX) | 03-Jun-24 | Private Sale | 1,500,000 | $54.75 | $82,125,000.00 | (17%) 8.75M to 7.25M | |
| 05-Jun-24 7:19 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 03-Jun-24 | Sale | 822,721 | $54.75 | $45,044,000.00 | (10%) 8.07M to 7.24M | |
| 04-Mar-24 7:31 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 29-Feb-24 | Disposition (other) | 577,478 | -- | -- | (6%) 9.32M to 8.74M | |
| 04-Mar-24 7:31 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 29-Feb-24 | Acquisition (other) | 44,544 | -- | -- | < 1% 9.72M to 9.76M | |
| 04-Mar-24 4:44 PM View: | Gujrathi Sheila Director | Janux Therapeutics, Inc. (JANX) | 29-Feb-24 | Acquisition (other) | 2,986 | -- | -- | 3% 105.04K to 108.03K | |
| 04-Mar-24 7:31 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 29-Feb-24 | Disposition (other) | 438,722 | -- | -- | (4%) 9.76M to 9.32M | |
| 04-Mar-24 4:33 PM View: | Capps Vickie L Director | Janux Therapeutics, Inc. (JANX) | 29-Feb-24 | Acquisition (other) | 1,493 | -- | -- | 2% 64.05K to 65.54K | |
| 15-Nov-23 4:46 PM View: | Lichter Jay Director 10% Owner | Janux Therapeutics, Inc. (JANX) | 13-Nov-23 | Private Purchase Duplicate | 849,854 | $5.87 | $4,988,640.00 | 10% 8.87M to 9.72M | |
| 13-Nov-23 7:11 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 13-Nov-23 | Private Purchase | 849,854 | $5.87 | $4,988,640.00 | 10% 8.87M to 9.72M | |
| 15-Nov-23 4:48 PM View: | Reardon Tighe Acting Chief Financial Officer 10% Owner | Janux Therapeutics, Inc. (JANX) | 13-Nov-23 | Private Purchase Duplicate | 849,854 | $5.87 | $4,988,640.00 | 19% 4.48M to 5.33M | |
| 21-Jul-23 4:31 PM View: | Ra Capital Management, LLC Director 10% Owner | Janux Therapeutics, Inc. (JANX) | 19-Jul-23 | Private Purchase | 495,008 | $12.46 | $6,167,800.00 | 6% 8.67M to 9.17M | |
| 30-Dec-21 8:55 PM View: | Thompson Peter A Director | Janux Therapeutics, Inc. (JANX) | 29-Dec-21 | Sale | 40,400 | $20.30 | $820,120.00 | (2%) 2.53M to 2.49M | |
| 30-Dec-21 9:00 PM View: | Orbimed Advisors LLC Director | Janux Therapeutics, Inc. (JANX) | 29-Dec-21 | Sale Duplicate | 40,400 | $20.30 | $820,120.00 | (2%) 2.53M to 2.49M | |
| 23-Dec-21 4:08 PM View: | Thompson Peter A Director | Janux Therapeutics, Inc. (JANX) | 21-Dec-21 | Sale | 119,400 | $19.00 | $2,268,600.00 | (5%) 2.65M to 2.53M | |
| 23-Dec-21 4:13 PM View: | Orbimed Advisors LLC Director | Janux Therapeutics, Inc. (JANX) | 21-Dec-21 | Sale Duplicate | 119,400 | $19.00 | $2,268,600.00 | (5%) 2.65M to 2.53M | |
| 17-Dec-21 5:16 PM View: | Thompson Peter A Director | Janux Therapeutics, Inc. (JANX) | 16-Dec-21 | Sale Duplicate | 393,300 | $19.07 | $7,500,230.00 | (13%) 3.04M to 2.65M | |
| 17-Dec-21 5:13 PM View: | Orbimed Advisors LLC Director | Janux Therapeutics, Inc. (JANX) | 16-Dec-21 | Sale | 393,300 | $19.07 | $7,500,230.00 | (13%) 3.04M to 2.65M | |
| 16-Jun-21 6:20 PM View: | Thompson Peter A Director | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Purchase Duplicate | 705,853 | $17.00 | $11,999,500.00 | 30% 2.34M to 3.04M | |
| 16-Jun-21 6:11 PM View: | Reardon Tighe Acting Chief Financial Officer 10% Owner | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Purchase Duplicate | 629,411 | $17.00 | $10,700,000.00 | 16% 4.02M to 4.65M | |
| 16-Jun-21 5:59 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Conversion | 4,195,070 | -- | -- | 2183% 192.15K to 4.39M | |
| 16-Jun-21 6:22 PM View: | Bregua Corp 10% Owner | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Conversion | 3,690,430 | -- | -- | 100% 0 to 3.69M | |
| 16-Jun-21 6:17 PM View: | Orbimed Advisors LLC Director | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Purchase | 705,853 | $17.00 | $11,999,500.00 | 30% 2.34M to 3.04M | |
| 16-Jun-21 6:05 PM View: | Lichter Jay Director 10% Owner | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Conversion | 8,045,150 | -- | -- | 4187% 192.15K to 8.24M | |
| 16-Jun-21 5:59 PM View: | Avalon Ventures Xi, L.P. 10% Owner | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Conversion | 3,850,080 | -- | -- | 88% 4.39M to 8.24M | |
| 16-Jun-21 5:21 PM View: | Ra Capital Management, LLC Director 10% Owner | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Conversion | 5,729,470 | -- | -- | 100% 0 to 5.73M | |
| 16-Jun-21 6:22 PM View: | Bregua Corp 10% Owner | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Purchase | 58,823 | $17.00 | $999,991.00 | 2% 3.69M to 3.75M | |
| 16-Jun-21 6:05 PM View: | Lichter Jay Director 10% Owner | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Purchase Duplicate | 629,411 | $17.00 | $10,700,000.00 | 8% 8.24M to 8.87M | |
| 16-Jun-21 6:20 PM View: | Thompson Peter A Director | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Conversion Duplicate | 2,336,910 | -- | -- | 100% 0 to 2.34M |
